search
Back to results

Effects of Kneehab 12-week Peri-operative Total Knee Arthroplasty (KneehabTKA)

Primary Purpose

Knee Osteoarthritis, Disuse Atrophy

Status
Completed
Phase
Phase 3
Locations
United Kingdom
Study Type
Interventional
Intervention
Standard Physiotherapy
Kneehab
Sponsored by
Bio-Medical Research, Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Kneehab, NMES, Total Knee Arthroplasty, Total Knee Replacement, TKA, Disuse atrophy, muscle hypertrophy, TKR, Atrophy Prevention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Individuals who are scheduled for elective Total Knee Replacement surgery
  • Individuals who are at least 18 years of age
  • Individuals with a body mass index (BMI) <40
  • Individuals who are walking independently with or without assistive devices
  • Must be able and willing to complete all study assessments and to be followed for the full course of the study.
  • Must be able to read, write and follow instructions in English.
  • Must be able and willing to provide informed consent.
  • Must be willing and able to attend for pre-op assessment

Exclusion Criteria:

  • Individuals who have failed the pre-operative assessment
  • Individuals with a history of foot and/or ankle pathology
  • Individuals with a history of tibial or femoral fractures
  • Individuals with a history of underlying neurological conditions
  • Individuals with physical conditions which would make them unable to perform study procedures
  • Individuals with a total hip replacement
  • Individuals undergoing revision TKA of the same operated leg
  • Pregnant women or inadequate precautions to prevent pregnancy
  • Diagnosis of a medical condition that would contraindicate treatment with the product,e.g skin lesions at electrode site.
  • Individuals with an active implanted medical device (i.e. pacemaker, pump)
  • Individuals with a history of stroke
  • Individuals with a history of neurological disorder that affects lower extremity function (stroke, peripheral neuropathy, Parkinson's disease, multiple sclerosis, etc.)
  • Individuals with a diagnosis of inflammatory arthritis (including Rheumatoid Arthritis, gout or psoriatic arthritis)
  • Individuals with muscle disease (i.e. muscular dystrophy)
  • Visible skin injury or disease on their legs
  • Principal investigator for this study, or member of study staff

Sites / Locations

  • Royal Liverpool and Broadgreen University Hospital NHS Trust

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Experimental

Arm Label

Control group standard physiotherapy

Kneehab

Arm Description

Standard pathway of care pre-and post-TKA without using NMES.

Kneehab on the quadriceps of the affected leg, 20 minutes, twice per day, 5 days per week over 12-week intervention (6 weeks pre-op, 6 weeks post op).

Outcomes

Primary Outcome Measures

Efficacy of Kneehab in promoting early recovery of quadriceps performance following knee arthoplasty.
Isometric muscle strength of the knee extensors will be measured by dynamometer with the knee flexed to 60°. Functional ability will be measured using the Timed Get Up and Go (TUG) and Stair Climb Test (SCT).

Secondary Outcome Measures

Determine the effect of Kneehab in promoting quality of life measures and health economic outcomes, compared to controls.
Administration of the Western Ontario McMaster University Osteoarthritis Index (WOMAC) and The Medical Outcomes Survey (SF-12). Health economic data will include patient length of stay post surgery; number of outpatient physiotherapy visits in the following year, and change in analgesic medication use during the 6 weeks pre- and 12 weeks post surgery.

Full Information

First Posted
March 24, 2010
Last Updated
July 18, 2014
Sponsor
Bio-Medical Research, Ltd.
Collaborators
Liverpool University Hospitals NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT01096524
Brief Title
Effects of Kneehab 12-week Peri-operative Total Knee Arthroplasty
Acronym
KneehabTKA
Official Title
Phase III Study Investigating the Effects of 6-weeks of Neuromuscular Electrical Stimulation (NMES) Peri-total Knee Arthroplasty (TKA).
Study Type
Interventional

2. Study Status

Record Verification Date
August 2013
Overall Recruitment Status
Completed
Study Start Date
March 2010 (undefined)
Primary Completion Date
June 2014 (Actual)
Study Completion Date
June 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Bio-Medical Research, Ltd.
Collaborators
Liverpool University Hospitals NHS Foundation Trust

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Determine the efficacy of neuromuscular electrical stimulation (NMES, Kneehab) in promoting accelerated recovery of quadriceps function in patients recovering from total knee arthroplasty (TKA) as measured by increases in isometric strength of the knee extensors and scores in the Timed Up and Go (TUG) test.
Detailed Description
Knee osteoarthritis is a severe debilitating condition that greatly impacts patient quality of life, function, emotional well-being and everyday pain levels. Total knee arthroplasty (TKA) is performed as a means of alleviating these symptoms in the long term however short term muscle weakness following surgery can elicit its own detrimental effect on performance and activities of daily living. This underlines the importance of mitigating strength loss in the immediate post-operative period. Recent reviews suggest that Neuromuscular Electrical Stimulation (NMES) of the quadriceps femoris muscle can be beneficial in the rehabilitation period following knee surgery. It appears that early use of NMES can help to recover exercise capacity in the muscle, thus allowing the patient to benefit more from volitional exercise therapy later in the rehabilitation period1. This in turn can lead to accelerated recovery and improved outcomes. A recent and as yet unpublished study of 96 patients following ACL reconstruction has demonstrated a clear benefit to the use of Kneehab. The benefit seemed to accrue in the six-week post-operative period. A recent pilot study by Walls 2 also suggests that NMES applied in the immediate pre-operative period before TKA leads to increased muscle strength and improved functional abilities. Previously, Mizner (2005) has shown pre operative strength to be a good predictor of functional outcome 1 year after surgery3. This proposed study aims to examine whether NMES applied in the peri-operative timeframe, 6 weeks before and 6 weeks after, can improve outcomes for patients undergoing total knee replacement. The rationale for this approach is that NMES can help prepare the quadriceps muscle for the rehabilitation phase by building exercise capacity before the operation. The immediate deficit, which normally follows knee surgery, would therefore be compensated to some extent and the post-operative NMES treatment would be expected to counteract the activation inhibition that is thought to occur in the early weeks following surgery. Overall, the patient would be in a better position to benefit from conventional rehabilitation exercises aimed at improved co-ordination and functional performance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis, Disuse Atrophy
Keywords
Kneehab, NMES, Total Knee Arthroplasty, Total Knee Replacement, TKA, Disuse atrophy, muscle hypertrophy, TKR, Atrophy Prevention

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control group standard physiotherapy
Arm Type
Other
Arm Description
Standard pathway of care pre-and post-TKA without using NMES.
Arm Title
Kneehab
Arm Type
Experimental
Arm Description
Kneehab on the quadriceps of the affected leg, 20 minutes, twice per day, 5 days per week over 12-week intervention (6 weeks pre-op, 6 weeks post op).
Intervention Type
Other
Intervention Name(s)
Standard Physiotherapy
Intervention Description
The Control group will complete the standard physiotherapy care pre and post-TKA surgery without NMES.
Intervention Type
Device
Intervention Name(s)
Kneehab
Other Intervention Name(s)
Neuromuscular Electrical Stimulation, NMES
Intervention Description
NMES 2 x 20 minute sessions/day, 5 days/week, 6 weeks pre and 6 weeks post TKA. Kneehab™ (Bio-Medical Research, Ltd., Galway, Ireland) is a NMES device with Multipath™ technology, designed to activate the quadriceps muscle. Kneehab™ is a battery operated, portable, 2-channel cutaneous electrical muscle stimulator, which operates using constant current pulses to stimulate the nerves innervating the quadriceps muscle. Kneehab™, consists of a thigh wrap with anatomically shaped electrodes and a control unit. Electrodes are placed over the quadriceps muscles and the garment is wrapped around the leg above the knee. Brief electrical impulses are delivered through the skin surface adhesive electrodes.
Primary Outcome Measure Information:
Title
Efficacy of Kneehab in promoting early recovery of quadriceps performance following knee arthoplasty.
Description
Isometric muscle strength of the knee extensors will be measured by dynamometer with the knee flexed to 60°. Functional ability will be measured using the Timed Get Up and Go (TUG) and Stair Climb Test (SCT).
Time Frame
6 weeks Pre-Op and 6, 12 and 52 weeks post op.
Secondary Outcome Measure Information:
Title
Determine the effect of Kneehab in promoting quality of life measures and health economic outcomes, compared to controls.
Description
Administration of the Western Ontario McMaster University Osteoarthritis Index (WOMAC) and The Medical Outcomes Survey (SF-12). Health economic data will include patient length of stay post surgery; number of outpatient physiotherapy visits in the following year, and change in analgesic medication use during the 6 weeks pre- and 12 weeks post surgery.
Time Frame
6 Weeks pre-Op and 6, 12 and 52 weeks post-Op

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Individuals who are scheduled for elective Total Knee Replacement surgery Individuals who are at least 18 years of age Individuals with a body mass index (BMI) <40 Individuals who are walking independently with or without assistive devices Must be able and willing to complete all study assessments and to be followed for the full course of the study. Must be able to read, write and follow instructions in English. Must be able and willing to provide informed consent. Must be willing and able to attend for pre-op assessment Exclusion Criteria: Individuals who have failed the pre-operative assessment Individuals with a history of foot and/or ankle pathology Individuals with a history of tibial or femoral fractures Individuals with a history of underlying neurological conditions Individuals with physical conditions which would make them unable to perform study procedures Individuals with a total hip replacement Individuals undergoing revision TKA of the same operated leg Pregnant women or inadequate precautions to prevent pregnancy Diagnosis of a medical condition that would contraindicate treatment with the product,e.g skin lesions at electrode site. Individuals with an active implanted medical device (i.e. pacemaker, pump) Individuals with a history of stroke Individuals with a history of neurological disorder that affects lower extremity function (stroke, peripheral neuropathy, Parkinson's disease, multiple sclerosis, etc.) Individuals with a diagnosis of inflammatory arthritis (including Rheumatoid Arthritis, gout or psoriatic arthritis) Individuals with muscle disease (i.e. muscular dystrophy) Visible skin injury or disease on their legs Principal investigator for this study, or member of study staff
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alasdair Santini, M.D.
Organizational Affiliation
Royal Liverpool & Broadgreen University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royal Liverpool and Broadgreen University Hospital NHS Trust
City
Liverpool
ZIP/Postal Code
L7 8XP
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
18201117
Citation
Paillard T. Combined application of neuromuscular electrical stimulation and voluntary muscular contractions. Sports Med. 2008;38(2):161-77. doi: 10.2165/00007256-200838020-00005.
Results Reference
background
PubMed Identifier
16078331
Citation
Mizner RL, Petterson SC, Stevens JE, Axe MJ, Snyder-Mackler L. Preoperative quadriceps strength predicts functional ability one year after total knee arthroplasty. J Rheumatol. 2005 Aug;32(8):1533-9.
Results Reference
background
PubMed Identifier
12919862
Citation
Stevens JE, Mizner RL, Snyder-Mackler L. Quadriceps strength and volitional activation before and after total knee arthroplasty for osteoarthritis. J Orthop Res. 2003 Sep;21(5):775-9. doi: 10.1016/S0736-0266(03)00052-4.
Results Reference
background
PubMed Identifier
17156487
Citation
Kennedy DM, Stratford PW, Hanna SE, Wessel J, Gollish JD. Modeling early recovery of physical function following hip and knee arthroplasty. BMC Musculoskelet Disord. 2006 Dec 11;7:100. doi: 10.1186/1471-2474-7-100.
Results Reference
background

Learn more about this trial

Effects of Kneehab 12-week Peri-operative Total Knee Arthroplasty

We'll reach out to this number within 24 hrs